Neuland Laboratories Ltd., a contract manufacturer of active pharmaceutical ingredients and intermediates, reports that one of its two main manufacturing units outside of Hyderabad, India, successfully completed an audit by the US Food and Drug Administration (FDA). The same unit had successfully completed a prior audit in 2010. Neuland's other manufacturing unit completed a similarly problem-free FDA audit in 2012.

Neuland provides products and services to customers in 85 countries, focusing on the US, Europe, and Japan, More than 90% of its business is in the US. Europe, and Japan

Source: Neuland Laboratories